NEW YORK (GenomeWeb News) – Sequenom said today that the underwriters of its recently completed public offering of common stock have exercised an option to acquire an additional 825,000 shares.
 
Last week, the firm offered 5.5 million shares of common stock at $15.50 per share.
 
The exercise of the over-allotment option brings the total number of shares sold to 6,325,000 and net proceeds to $92 million.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

In Science this week: in vitro generation of human reproductive cells, and more.